We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Circuit Court Sides With PTAB on Invalidating J&J’s Remicade Patent
Circuit Court Sides With PTAB on Invalidating J&J’s Remicade Patent
A federal circuit court upheld a PTO Patent Trial and Appeal Board ruling that a Johnson & Johnson patent for Remicade, which earned the company nearly $7 billion in 2016, is invalid.